Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
Mumbai, IN
Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of branded packaged fast-moving consumer goods, with a particular emphasis on feminine care and healthcare segments. Its product range within healthcare includes various topical solutions like ointments and creams, as well as cough suppressants and medicinal tablets. For hygiene, it offers feminine hygiene essentials, such as pads, alongside other skin-focused hygiene items. The comprehensive portfolio extends further to cover baby care products, including nappies, pants, and wipes, along with diverse lines for laundry, hair care, home care, and oral care. These offerings are marketed under prominent brands such as Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice. The company's goods are made available to consumers through an extensive network of retail channels, encompassing mass merchandisers, grocery stores, membership clubs, pharmacies, department stores, and various high-frequency retail outlets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.30% | +0.56% | -4.60% | -14.72% | -24.11% | -25.37% | -28.12% | -28.46% | -26.26% | +56.26% | +2,410.05% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+7.3% ★ Q1'26: -5.2% (vs Q4'24)
-
EPS growth Household & Personal Products: +8.8%+25.7% ★ Q1'26: -1.9% (vs Q4'24)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+18.0% ★ Q1'26: +55.1% (vs Q4'24)
-
EBIT margin Household & Personal Products: +9.9%+26.0% ★ Q1'26: +23.6% (vs Q4'24)
-
ROIC Household & Personal Products: +8.2%+386.1% ★ Q1'26: +333.3% (vs Q4'24)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.00× Q1'26: 0.00× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 1996 actual |
Jun 1997 actual |
Jun 1998 actual |
Jun 1999 actual |
Jun 2000 actual |
Jun 2001 actual |
Jun 2005 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 2 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.27B
est.
|
4.70B
est.
|
3.90B
est.
|
4.34B
est.
|
4.44B
est.
|
4.56B
est.
|
6.85B
est: 7.01B (-2.3%)
|
12.95B
est: 13.11B (-1.2%)
|
16.85B
est: 16.96B (-0.7%)
|
20.47B
est: 21.22B (-3.5%)
|
23.32B
est: 23.32B (+0.0%)
|
22.73B
est: 25.74B (-11.7%)
|
23.20B
est: 25.74B (-9.9%)
|
24.55B
est: 25.86B (-5.0%)
|
29.42B
est: 25.03B (+17.6%)
|
29.99B
est: 28.90B (+3.7%)
|
35.70B
est: 29.31B (+21.8%)
|
37.92B
est: 34.95B (+8.5%)
|
39.05B
est: 38.00B (+2.8%)
|
41.92B
est: 42.32B (-0.9%)
|
44.99B
est: 42.32B (+6.3%)
|
48.65B
48.65B – 48.65B
+15.0% YoY
|
53.19B
53.19B – 53.19B
+9.3% YoY
|
52.15B
51.83B – 52.47B
-2.0% YoY
|
| EBITDA |
1.04B
est.
|
766.50M
est.
|
631.47M
est.
|
774.36M
est.
|
886.63M
est.
|
1.09B
est.
|
1.80B
est: 1.68B (+6.9%)
|
2.51B
est: 3.09B (-18.8%)
|
3.18B
est: 3.76B (-15.6%)
|
5.01B
est: 4.73B (+5.8%)
|
5.59B
est: 6.26B (-10.7%)
|
6.93B
est: 6.90B (+0.5%)
|
7.42B
est: 7.31B (+1.5%)
|
6.39B
est: 8.19B (-21.9%)
|
6.63B
est: 7.49B (-11.6%)
|
6.48B
est: 6.98B (-7.2%)
|
9.24B
est: 7.09B (+30.2%)
|
8.54B
est: 8.50B (+0.6%)
|
9.09B
est: 9.24B (-1.6%)
|
10.23B
est: 10.48B (-2.4%)
|
12.11B
est: 10.41B (+16.4%)
|
11.97B
11.97B – 11.97B
+15.0% YoY
|
13.08B
13.08B – 13.08B
+9.3% YoY
|
12.68B
12.60B – 12.75B
-3.1% YoY
|
| EBIT |
982.43M
est.
|
659.20M
est.
|
543.08M
est.
|
665.96M
est.
|
699.89M
est.
|
929.22M
est.
|
1.68B
est: 1.43B (+17.3%)
|
2.23B
est: 2.62B (-15.0%)
|
2.86B
est: 2.36B (+21.5%)
|
4.66B
est: 2.85B (+63.7%)
|
5.07B
est: 4.33B (+17.1%)
|
6.42B
est: 4.91B (+30.6%)
|
6.82B
est: 5.35B (+27.6%)
|
5.87B
est: 6.25B (-6.1%)
|
6.13B
est: 6.70B (-8.6%)
|
6.00B
est: 6.65B (-9.8%)
|
8.76B
est: 6.74B (+29.9%)
|
8.01B
est: 8.04B (-0.4%)
|
8.51B
est: 8.08B (+5.3%)
|
9.66B
est: 9.86B (-2.0%)
|
11.69B
est: 9.86B (+18.5%)
|
11.33B
11.33B – 11.33B
+15.0% YoY
|
12.39B
12.39B – 12.39B
+9.3% YoY
|
12.00B
11.93B – 12.07B
-3.1% YoY
|
| Net Income |
166.72M
est.
|
475.42M
est.
|
391.67M
est.
|
480.29M
est.
|
582.22M
est.
|
760.00M
est.
|
1.25B
est: 1.17B (+6.6%)
|
1.81B
est: 2.15B (-15.6%)
|
2.03B
est: 2.35B (-13.4%)
|
3.02B
est: 2.54B (+18.8%)
|
3.46B
est: 3.36B (+3.0%)
|
4.23B
est: 3.82B (+10.5%)
|
4.33B
est: 4.04B (+7.1%)
|
3.75B
est: 4.41B (-15.1%)
|
4.19B
est: 4.36B (-3.8%)
|
4.33B
est: 4.48B (-3.4%)
|
6.52B
est: 4.98B (+30.9%)
|
5.76B
est: 5.91B (-2.5%)
|
6.78B
est: 6.29B (+7.7%)
|
6.75B
est: 8.78B (-23.2%)
|
8.49B
est: 8.78B (-3.4%)
|
9.05B
9.05B – 9.05B
+3.1% YoY
|
10.04B
9.76B – 10.32B
+10.9% YoY
|
10.86B
10.78B – 10.95B
+8.2% YoY
|
| SGA |
811.66M
est.
|
1.80B
est.
|
1.48B
est.
|
1.82B
est.
|
1.56B
est.
|
1.56B
est.
|
1.79B
est: 2.40B (-25.2%)
|
2.48B
est: 4.41B (-43.7%)
|
5.41B
est: 5.92B (-8.5%)
|
6.07B
est: 8.28B (-26.7%)
|
3.03B
est: 7.18B (-57.7%)
|
3.33B
est: 7.77B (-57.1%)
|
3.24B
est: 4.93B (-34.3%)
|
4.04B
est: 5.04B (-19.9%)
|
4.80B
est: 6.83B (-29.7%)
|
4.88B
est: 5.50B (-11.1%)
|
7.13B
est: 5.60B (+27.4%)
|
6.78B
est: 6.52B (+4.1%)
|
6.23B
est: 7.29B (-14.5%)
|
7.75B
est: 8.81B (-12.0%)
|
14.30B
est: 8.81B (+62.3%)
|
10.13B
10.13B – 10.13B
+15.0% YoY
|
11.07B
11.07B – 11.07B
+9.3% YoY
|
9.91B
9.85B – 9.98B
-10.5% YoY
|
| EPS |
5.14
est.
|
6.10
est.
|
9.04
est.
|
12.29
est.
|
13.68
est.
|
15.62
est.
|
38.39
est: 29.74 (+29.1%)
|
55.85
est: 55.87 (0.0%)
|
62.61
est: 61.87 (+1.2%)
|
93.04
est: 84.83 (+9.7%)
|
106.63
est: 103.00 (+3.5%)
|
130.16
est: 128.78 (+1.1%)
|
133.31
est: 128.78 (+3.5%)
|
115.40
est: 145.13 (-20.5%)
|
129.12
est: 131.62 (-1.9%)
|
133.42
est: 138.15 (-3.4%)
|
200.79
est: 153.40 (+30.9%)
|
177.37
est: 182.00 (-2.5%)
|
208.91
est: 196.80 (+6.2%)
|
207.95
est: 270.60 (-23.2%)
|
261.48
est: 270.60 (-3.4%)
|
278.90
278.90 – 278.90
+3.1% YoY
|
309.30
300.63 – 317.97
+10.9% YoY
|
334.70
332.03 – 337.37
+8.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Madhusudan Gopalan | Senior Vice President of Grooming & Oral Care and P&G Japan & Korea | 53M | male |
| Kumar Venkatasubramanian | MD, Chief Executive Officer & Director | 49M | male |
| Ghanashyam | Legal Head, Company Secretary, Compliance Officer & Executive Director | 20M | male |
| Mukta Maheshwari | Chief Marketing Officer | — | female |
| Robin Thadathil | Chief Human Resources Officer | — | male |
| Rohini Laya Venkateswaran | Head of Sales | — | female |
| Enakshee Deva | Head of CSR & Communications | — | male |
| Sachan Saini | Government Relations Head | — | male |
| Gaurav Bhartia | Chief Financial Officer | — | male |
| John T. Chevalier | Chief Investor Relations Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PGHH.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
